Associations Between Patient Experience With Care, Race and Ethnicity, and Receipt of CRC Treatment Among SEER-CAHPS Patients With Multiple Comorbidities
- PMID: 38150827
- PMCID: PMC10872498
- DOI: 10.6004/jnccn.2023.7074
Associations Between Patient Experience With Care, Race and Ethnicity, and Receipt of CRC Treatment Among SEER-CAHPS Patients With Multiple Comorbidities
Abstract
Background: Patients with colorectal cancer (CRC) and multiple comorbidities are less likely to receive guideline-concordant treatment (GCT), a disparity exacerbated by racial and ethnic disparities in GCT. Yet, positive patient experiences with care are associated with more appropriate care use. We investigated associations between patient experiences with care, race and ethnicity, and receipt of GCT for CRC among older adults with multiple comorbidities.
Methods: We used SEER-Consumer Assessment of Healthcare Providers and Systems (CAHPS) data to identify participants diagnosed with CRC from 2001 to 2017 at age ≥67 years with additional chronic conditions. Stage-specific GCT was identified following recommendations in the NCCN Guidelines for Colon and Rectal Cancer. Patient experiences with care were identified from CAHPS surveys. Multivariable log-binomial regression estimated associations between race and ethnicity and receipt of GCT by experiences with care.
Results: A total of 2,612 patients were included. Those reporting excellent experience with getting care quickly were 5% more likely to receive GCT than those reporting less-than-excellent experience (relative risk [RR], 1.05; 95% CI, 1.04-1.05). When reporting less-than-excellent experience with getting care quickly, non-Hispanic Black (NHB) patients were less likely than non-Hispanic White (NHW) patients to receive GCT (RR, 0.80; 99.38% CI, 0.78-0.82), yet NHB patients were more likely to receive GCT than NHW patients when reporting excellent experience (RR, 1.05; 99.38% CI, 1.02-1.09). When reporting less-than-excellent experience with getting needed care, Hispanic patients were less likely than NHW patients to receive GCT (RR, 0.91; 99.38% CI, 0.88-0.94), yet Hispanic patients were more likely to receive GCT than NHW patients when reporting excellent experience (RR, 1.06; 99.38% CI, 1.03-1.08).
Conclusions: Although excellent patient experience among those with multiple comorbidities may not be strongly associated with receipt of GCT for CRC overall, improvements in experiences of accessing care among NHB and Hispanic patients with CRC and additional comorbidities may aid in mitigating racial and ethnic disparities in receipt of GCT.
Keywords: colorectal cancer; guideline care; older adult care; patient experience; racial and ethnic disparity.
Similar articles
-
Racial/Ethnic Disparities in Patient Experiences With Health Care in Association With Earlier Stage at Colorectal Cancer Diagnosis: Findings From the SEER-CAHPS Data.Med Care. 2021 Apr 1;59(4):295-303. doi: 10.1097/MLR.0000000000001514. Med Care. 2021. PMID: 33528232
-
Healthcare Experiences Are Associated with Colorectal Cancer Mortality but only for Specific Racial Groups: a SEER-CAHPS Study.J Racial Ethn Health Disparities. 2024 Aug;11(4):2224-2235. doi: 10.1007/s40615-023-01690-7. Epub 2023 Jun 27. J Racial Ethn Health Disparities. 2024. PMID: 37369914 Free PMC article.
-
Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study.Cancer Causes Control. 2024 Apr;35(4):647-659. doi: 10.1007/s10552-023-01834-4. Epub 2023 Nov 25. Cancer Causes Control. 2024. PMID: 38001335
-
Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study.J Geriatr Oncol. 2023 Jul;14(6):101554. doi: 10.1016/j.jgo.2023.101554. Epub 2023 Jun 13. J Geriatr Oncol. 2023. PMID: 37320932 Free PMC article.
-
Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study.Cancer Causes Control. 2022 Apr;33(4):601-612. doi: 10.1007/s10552-022-01552-3. Epub 2022 Jan 15. Cancer Causes Control. 2022. PMID: 35032242
References
-
- Lemmens VE, Janssen-Heijnen ML, Verheij CD, et al. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005;92:615–623. - PubMed
-
- Etzioni DA, El-Khoueiry AB, Beart RW Jr. Rates and predictors of chemo-therapy use for stage III colon cancer: a systematic review. Cancer 2008; 113:3279–3289. - PubMed
-
- Gross CP, McAvay GJ, Guo Z, et al. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 2007;109:2410–2419. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
